title: Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
authors.affiliation: The Queen's Medical Research Institute, 3rd Floor East, Room E3.23, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. bean.dhaun@ed.ac.uk.
authors.forename: J P
authors.initials: JP
authors.lastname: Blackmur
authors.forename: F A
authors.initials: FA
authors.lastname: Chapman
authors.forename: C O
authors.initials: CO
authors.lastname: Bellamy
authors.forename: V
authors.initials: V
authors.lastname: Save
authors.forename: J N
authors.initials: JN
authors.lastname: Plevris
authors.forename: A G
authors.initials: AG
authors.lastname: Shand
authors.forename: C
authors.initials: C
authors.lastname: Whitworth
authors.forename: N
authors.initials: N
authors.lastname: Dhaun
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab